Article
Plasma CD93 concentration is a potential novel biomarker for coronary artery disease.
Journal of internal medicine - 1 Sept 2011
Mälarstig A, Silveira A, Wågsäter D, Öhrvik J, Bäcklund A, Samnegård A, Khademi M, Hellenius M-L, Leander K, Olsson T, Uhlén M, de Faire U, Eriksson P, Hamsten A
Abstract excerpt
OBJECTIVES: A common nonsynonymous single nucleotide polymorphism (SNP) in the CD93 gene (rs3746731, Pro541Ser) has been associated with risk of coronary artery disease (CAD). CD93 is a transmembrane glycoprotein, which is detectable in soluble form in human plasma. We investigated whether the concentration of soluble CD93 in plasma is related to risk of myocardial infarction (MI) and CAD, using a case-control...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
